Key result
Bretschneider-HTK and cold blood cardioplegia provided similar overall myocardial protection, but HTK yielded lower cTnI peak values in patients with cross-clamp times >160 minutes.
Why the study?
Does Bretschneider-HTK cardioplegia improve myocardial protection compared to cold blood cardioplegia in patients undergoing thoracic aorta operations?
Cohort (n=112)
Does Bretschneider-HTK cardioplegia improve myocardial protection compared to cold blood cardioplegia in patients undergoing thoracic aorta operations?
Answers are grounded in this paper and cite their sources.
Bretschneider-HTK and cold blood cardioplegia provide similar overall myocardial protection during thoracic aorta surgery, but HTK may offer superior protection (lower cTnI release) during prolonged cross-clamp times (>160 min).
The ideal cardioplegic strategy in thoracic aorta operations requiring long cardiopulmonary bypass and cross-clamp time has not been established. Suboptimal myocardial protection may lead to myocardial damage and possible post-operative complications. We evaluate post-operative cardiac Troponin I (cTnI) release, low cardiac output syndrome (LCOS) and mortality, using a cold crystalloid single-dose intracellular or cold blood multidose cardioplegia in 112 elective or emergent thoracic aorta operation patients. Fifty-four patients (HTK group) received Custodiol® cardioplegic solution and 58 received cold blood cardioplegia (CB group). Cross-clamp time, cardiopulmonary bypass (CPB) time and cTnI peak release were similar in both groups. No differences were found for atrial and ventricular arrhythmias, inotropic support, LCOS and in-hospital mortality. Two-way ANOVA analysis revealed an interactive effect on cTnI peak (p=0.012) of cardioplegic solution type across the cross-clamp time quintile. In the fifth quintile, cross-clamp time patient (>160 min) cTnI peak value was higher in CB patients (p=0.044). HTK and CB cardioplegic solutions assure similar myocardial protection in patients undergoing thoracic aorta operations. In long cross-clamp times, the lower post-operative cTnI release detected using HTK may be indicative of a better myocardial protection in these extreme conditions.
No takes yet. Share an insight, caveat, or question.
Scrascia et al. (2011) conducted a cohort in Thoracic aorta operations (n=112). Bretschneider-HTK (Custodiol) cardioplegic solution vs. Cold blood multidose cardioplegia was evaluated on Post-operative cardiac Troponin I (cTnI) release, low cardiac output syndrome (LCOS), and mortality. Bretschneider-HTK and cold blood cardioplegia provided similar overall myocardial protection, but HTK yielded lower cTnI peak values in patients with cross-clamp times >160 minutes.
Synapse has enriched 10 related papers. Consider them for comparative context: